Pfizer Inc
Registered Principal Details
Business Or Interest:
Pharmaceutical manufacturing and healthcare.
Lobbying Interests:
All matters affecting the pharmaceutical manufacturing and healthcare industries
CEO Name:
Ian Read
Director, Government Relations
Pharmaceutical manufacturing and healthcare.
Lobbying Interests:
All matters affecting the pharmaceutical manufacturing and healthcare industries
CEO Name:
Ian Read
Director, Government Relations
Contact
JD
James DeMay
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815
Sausalito, CA 94965
(415) 903-2800
(415) 610-7604
jskelton@politicomlaw.com
http://www.pfizer.com
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815
Sausalito, CA 94965
(415) 903-2800
(415) 610-7604
jskelton@politicomlaw.com
http://www.pfizer.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| James DeMay | Exclusive Duties N/A | Authorized On 12/28/2016 | Withdrawn On N/A |
| Tony Langenohl | Exclusive Duties N/A | Authorized On 12/28/2016 | Withdrawn On N/A |
| William J McCoshen | Exclusive Duties N/A | Authorized On 12/28/2016 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 306
Relating to: tracking the sale of pseudoephedrine products.
Bill Text and History
2017 Wisconsin Act 98
11/13/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: tracking the sale of pseudoephedrine products.
Bill Text and History
2017 Wisconsin Act 98
For
Notification Date11/13/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 679
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
12/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
For
Notification Date12/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 237
Relating to: tracking the sale of pseudoephedrine products.
Bill Text and History
12/13/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: tracking the sale of pseudoephedrine products.
Bill Text and History
For
Notification Date12/13/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 575
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
2017 Wisconsin Act 149
12/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
2017 Wisconsin Act 149
For
Notification Date12/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Substitution of interchangeable biosimilars
Substitution of interchangeable biosimilars
Action Intended To Affect
Both Legislative matter and rule
Notification Date
10/6/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
10/6/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Legal Reform Bills
Legal Reform Bills
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Fetal Tissue Research Ban
Fetal Tissue Research Ban
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Medicaid Issues
Medicaid Issues
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Behavioral Health Issues
Behavioral Health Issues
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Substance Abuse Treatment
Substance Abuse Treatment
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Pain Management Issues
Pain Management Issues
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Vaccines and immunizations
Vaccines and immunizations
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Regulation of the Pharmaceutical Industry
Regulation of the Pharmaceutical Industry
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Prescribing Opioids
Prescribing Opioids
Action Intended To Affect
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2017 January - June $28,029.93 |
2017 July - December $25,448.00 |
2018 January - June $26,834.13 |
2018 July - December $26,547.30 |
Total $106,859.36 |
| Total Hours Communicating | 2017 January - June 7.50 |
2017 July - December 9.00 |
2018 January - June 0.00 |
2018 July - December 7.50 |
Total 24.00 |
| Total Hours Other | 2017 January - June 42.00 |
2017 July - December 48.50 |
2018 January - June 72.50 |
2018 July - December 54.50 |
Total 217.50 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: tracking the sale of pseudoephedrine products.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 10% |
2018 January - June |
2018 July - December |
Total 2% |
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 15% |
2018 January - June |
2018 July - December |
Total 4% |
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 15% |
2018 January - June 60% |
2018 July - December |
Total 22% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 1% |
2017 July - December |
2018 January - June |
2018 July - December |
Total < 1% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 1% |
2017 July - December |
2018 January - June 10% |
2018 July - December 10% |
Total 6% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 1% |
2017 July - December |
2018 January - June |
2018 July - December |
Total < 1% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 4% |
2017 July - December |
2018 January - June |
2018 July - December |
Total < 1% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 6% |
2017 July - December 10% |
2018 January - June 10% |
2018 July - December |
Total 7% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 7% |
2017 July - December |
2018 January - June |
2018 July - December |
Total 1% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 7% |
2017 July - December |
2018 January - June 10% |
2018 July - December 20% |
Total 10% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 12% |
2017 July - December 10% |
2018 January - June 10% |
2018 July - December 70% |
Total 26% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 53% |
2017 July - December 10% |
2018 January - June |
2018 July - December |
Total 13% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 30% |
2018 January - June |
2018 July - December |
Total 7% |
Minor Efforts
No minor efforts found.
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication